Cargando…
A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received
Vaccines have allowed for a significant decrease in COVID-19 risk, and new antiviral medications can prevent disease progression if given early in the course of the disease. The rapid and accurate estimation of the risk of severe disease in new patients is needed to prioritize the treatment of high-...
Autores principales: | Israel, Ariel, Schäffer, Alejandro A., Merzon, Eugene, Green, Ilan, Magen, Eli, Golan-Cohen, Avivit, Vinker, Shlomo, Ruppin, Eytan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229599/ https://www.ncbi.nlm.nih.gov/pubmed/35744754 http://dx.doi.org/10.3390/microorganisms10061238 |
Ejemplares similares
-
Predicting COVID-19 severity using major risk factors and received vaccines
por: Israel, Ariel, et al.
Publicado: (2022) -
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
por: Israel, Ariel, et al.
Publicado: (2021) -
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
por: Israel, Ariel, et al.
Publicado: (2021) -
Elapsed time since BNT162b2 vaccine and
risk of SARS-CoV-2 infection: test negative design study
por: Israel, Ariel, et al.
Publicado: (2021) -
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
por: Israel, Ariel, et al.
Publicado: (2021)